{
  "chapters": [
    {
      "number": 1,
      "title": "Intro",
      "durationSec": 32,
      "positionSec": 0
    },
    {
      "number": 2,
      "title": "Begrüßung",
      "durationSec": 193,
      "positionSec": 32
    },
    {
      "number": 3,
      "title": "Feedback: China",
      "durationSec": 538,
      "positionSec": 226
    },
    {
      "number": 4,
      "title": "Feedback: Patente und mRNA-Technologie",
      "durationSec": 1815,
      "positionSec": 764
    },
    {
      "number": 5,
      "title": "Infektionszahlen in Deutschland",
      "durationSec": 490,
      "positionSec": 2580
    },
    {
      "number": 6,
      "title": "Tests und Positienrate",
      "durationSec": 211,
      "positionSec": 3071
    },
    {
      "number": 7,
      "title": "Fortschritt der Impfkampagne",
      "durationSec": 1288,
      "positionSec": 3282
    },
    {
      "number": 8,
      "title": "WHO erteilt Notfallzulassung für Sinopharm",
      "durationSec": 48,
      "positionSec": 4571
    },
    {
      "number": 9,
      "title": "WHO: B.1.617 ist eine Variant of Concern (VoC)",
      "durationSec": 72,
      "positionSec": 4620
    },
    {
      "number": 10,
      "title": "USA lässt BP für 12-15-jährige zu",
      "durationSec": 251,
      "positionSec": 4692
    },
    {
      "number": 11,
      "title": "Digitaler Impfpass",
      "durationSec": 435,
      "positionSec": 4943
    },
    {
      "number": 12,
      "title": "Corona-Warn-App",
      "durationSec": 89,
      "positionSec": 5378
    },
    {
      "number": 13,
      "title": "\"Krise\" in Taiwan",
      "durationSec": 422,
      "positionSec": 5468
    },
    {
      "number": 14,
      "title": "Ausblick",
      "durationSec": 424,
      "positionSec": 5890
    },
    {
      "number": 15,
      "title": "Bonus Track",
      "durationSec": 175,
      "positionSec": 6315
    }
  ]
}